In this interactive case-based activity, Mihaela Cristea, MD, City of Hope, will discuss emerging data on PARP inhibitors in the management of recurrent ovarian cancer and case studies that provide a framework for personalized care plans.

Join Caroline Behler, MD,, on May 1 at 6:30PM to review data from 2 pivotal trials assessing Adcetris+AVD vs ABVD in previously untreated Stage III/IV classical Hodgkin lymphoma (cHL), and Adcetris+CHP vs CHOP in previously untreated CD30-expressing peripheral T-cell lymphoma (PTCL).

The AIM Planning Committee invites you to attend this Inaugural AIM Investigator Conference.

This exciting one-day conference will feature a lineup of nationally-recognized speakers who will address payment reform, medical-dental integration, health plan perspectives, and other current topics.

Join Caroline Behler, MD, as she reviews data from 2 pivotal trials assessing Adcetris+AVD vs ABVD in previously untreated Stage III/IV classical Hodgkin lymphoma (cHL), and Adcetris+CHP vs CHOP in previously untreated CD30-expressing peripheral T-cell lymphomas (PTCL).

Join Babis Andreadis, MD, UC San Francisco, Brian A. Jonas, MD, PhD, UC Davis, and Michaela Liedtke, MD, Stanford University as they present the latest treatment modalities for hematologic malignancies. Alfred Chung, MD, Stanford University will then present cases for discussion illustrating the new treatment modalities.

On July 1, 2017, California' out-of-network billing and payment law (AB 72) went into effect. This law changed the billing practices of non-participating physicians providing non-emergent care at in-network facilities by requiring payors to reimburse at an interim payment rate. This law also created a dispute resolution mechanism for physicians who believe the interim payment...

The California Prostate Cancer Coalition (CPCC) and the Helen Diller Family Comprehensive Cancer Center of UC San Francisco proudly present this national conference for patients, families, caregivers, health care professionals and advocates.

California's proposed FY2020 budget includes a value-based payment incentive to providers through Medi-Cal managed care plans for meeting specific measures aimed at improving care for certain high-cost or high-need populations. The California Department of Health Care Services will discuss how they selected the proposed measures, the measure payment method, and purpose of the measures. The...

The Multinational Association of Supportive Care in Cancer joins with the International Society of Oral Oncology (ISOO) to convene the MASCC/ISOO Annual Meeting. Topics address new treatments and technologies to manage the symptoms of cancer and side effects of therapy, as well as psychosocial and economic concerns.